We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$456M
AUM Growth
+$2.09M
Cap. Flow
-$9.77M
Cap. Flow %
-2.14%
Top 10 Hldgs %
14.03%
Holding
362
New
46
Increased
61
Reduced
100
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.2M
2
IVZ icon
Invesco
IVZ
+$3.16M
3
DELL icon
Dell
DELL
+$2.9M
4
PFE icon
Pfizer
PFE
+$2.83M
5
JNPR
Juniper Networks
JNPR
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 15.25%
2 Consumer Discretionary 14.74%
3 Materials 12.22%
4 Technology 12.17%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBBN icon
76
Ribbon Communications
RBBN
$377M
$2.14M 0.47%
353,600
+43,600
+14% +$259K
INGN icon
77
Inogen
INGN
$177M
$2.12M 0.47%
62,400
+400
+0.6% +$14.5K
LNC icon
78
Lincoln National
LNC
$8.93B
$2.12M 0.46%
31,000
FXE icon
79
Invesco CurrencyShares Euro Currency Trust
FXE
$340M
$2.12M 0.46%
20,000
TBCH
80
Turtle Beach Corp
TBCH
$244M
$2.08M 0.46%
93,600
+16,100
+21% +$435K
KGC icon
81
Kinross Gold
KGC
$30.5B
$2.06M 0.45%
354,000
-10,000
-3% -$59.8K
MOS icon
82
The Mosaic Company
MOS
$7.43B
$2.04M 0.45%
52,000
M icon
83
Macy's
M
$6.68B
$2.04M 0.45%
78,000
-26,000
-25% -$709K
HCA icon
84
HCA Healthcare
HCA
$88.4B
$2M 0.44%
+7,800
New +$1.91M
JAZZ icon
85
Jazz Pharmaceuticals
JAZZ
$16.8B
$1.99M 0.44%
15,600
-9,200
-37% -$1.21M
CSCO icon
86
Cisco
CSCO
$477B
$1.98M 0.43%
+31,200
New +$1.78M
INFY icon
87
Infosys
INFY
$50.3B
$1.97M 0.43%
78,000
+500
+0.6% +$11.6K
HPQ icon
88
HP
HPQ
$25.9B
$1.96M 0.43%
52,000
-41,000
-44% -$1.34M
VVV icon
89
Valvoline
VVV
$4.58B
$1.94M 0.43%
52,000
-10,000
-16% -$349K
WAT icon
90
Waters Corp
WAT
$38.8B
$1.94M 0.43%
+5,200
New +$1.82M
T icon
91
AT&T
T
$162B
$1.92M 0.42%
+103,272
New +$1.93M
LYB icon
92
LyondellBasell Industries
LYB
$20B
$1.92M 0.42%
20,800
-4,000
-16% -$371K
ORI icon
93
Old Republic International
ORI
$10.5B
$1.92M 0.42%
78,000
+26,000
+50% +$646K
FIZZ icon
94
National Beverage
FIZZ
$2.97B
$1.89M 0.41%
41,600
+10,400
+33% +$566K
HIBB
95
DELISTED
Hibbett, Inc. Common Stock
HIBB
$1.87M 0.41%
26,000
-15,600
-38% -$1.24M
KHC icon
96
Kraft Heinz
KHC
$29.8B
$1.87M 0.41%
52,000
+14,800
+40% +$532K
RRC icon
97
Range Resources
RRC
$9.04B
$1.82M 0.4%
102,000
-10,000
-9% -$216K
WSM icon
98
Williams-Sonoma
WSM
$29B
$1.76M 0.39%
20,800
-4,000
-16% -$373K
CLFD icon
99
Clearfield
CLFD
$358M
$1.76M 0.39%
20,800
-41,200
-66% -$2.59M
GIS icon
100
General Mills
GIS
$19.3B
$1.75M 0.38%
26,000
-11,200
-30% -$711K

Similar funds

Hussman Strategic Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Hussman Strategic Advisors held 362 positions worth $456M, up 0.46% from $454M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors's Q4 2021 filing shows 46 new, 61 increased, 100 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M. The largest sale was Meredith Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Hussman Strategic Advisors's largest Q4 2021 buy was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M.
  • Hussman Strategic Advisors added most to Newmont in Q4 2021, an estimated $2.27M increase.
  • Hussman Strategic Advisors's biggest Q4 2021 reduction was Clearfield, cutting an estimated $2.59M.
  • Hussman Strategic Advisors fully exited Meredith Corporation in Q4 2021, selling an estimated $2.9M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $456M portfolio in Q4 2021.
  • Hussman Strategic Advisors opened 46 new positions and closed 43 in Q4 2021.
  • Hussman Strategic Advisors's portfolio value rose 0.46% quarter-over-quarter to $456M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.